Background and Aims: Volumetric CT has been widely used to
phenotype COPD patients. A mixed phenotype is defined as the presence of both emphysema and airway wall thickening on volumetric CT. Longterm clinical courses of this phenotype has not been studied in depth.
This study aimed to compare baseline clinical characteristics and clinical course of the mixed phenotype to other phenotypes of COPD patients.
Methods: Patients enrolled in the Korean Obstructive Lung Disease (KOLD) study from June 2005 to October 2015 were evaluated for this study. The patients were spirometrically diagnosed with COPD and had a smoking history of more than 10 pack-years. Volumetric CT scans were performed for each patient upon enrolment in the cohort and annual follow up pulmonary function tests were performed for at least 3 years. The emphysema index and the percentage of bronchial mean wall area percentage were calculated from the volumetric CT. Patients with COPD were classified into four distinct phenotypes using two cutoffs: emphysema index of 15% and median value of mean wall area (%) (MWA%).
Results: Of 261 patients with COPD, 51 (19.5%) were classified as CT-normal phenotype, 71 (27.2%) as airway-dominant phenotype, 80 (30.7%) as emphysema dominant phenotype and 59 (22.6%) as mixed phenotype. The patients in the mixed phenotype showed the highest baseline SGRQ-score among the four phenotypes with significant difference (P < 0.001). Overall survival of the four phenotypes were evaluated using Kaplan-Meier curve analysis, showing significantly shorter survival time in patients in the mixed phenotype (Figure, P < 0.01). There was no significant difference in frequency of COPD exacerbations between the phenotypes (P = 0.157). FEV1 (%) decline over 3 years was most prominent in the mixed phenotype (-9.9%+-10.4) compared to the other phenotypes (P = 0.032).
Conclusion:
The patients in the mixed phenotype showed relatively higher SGRQ score, and shorter survival when compared to other phenotypes. 
Linkou, Taiwan
Background and Aims: Recently before 2015, a health system that provides better care, spends dollars more wisely, and has healthier people was mentioned (Burwell SM NEJM 2015/Jan/26). One of the three major aspects (incentives, care delivery and information) suggested 'bring electronic health information to the point of care for meaningful use'.
Another systematic review article concluded 'strongly support pulmonary rehabilitation, including at least four weeks of exercise training, as part of the spectrum of treatment for patients with COPD.' (McCarthy B et al Cochrane Reviews 2015) . Therefore, we propose a protocol for PR on COPD GOLD B/C/D with mobile apps.
Methods: A randomized controlled trial named 'BIG-apps' study (Breathing Is Getting apps) was designed. Enrolment: out-patientdepartment patients with GOLD category B, C to D since 2018/July/1 to 2020/June/30. BIG-apps includes an online social society discussion group via line, facebook WeChat or twitter. A mobile app named 'instant heart rate' designed by azumio™ was installed initially to mobile phone for real-time heart rate monitoring. Randomization is on a 2:1 ratio for intervention-to-control. The intervention arm had well-organized PR information by education of deep-inspiration, pursed lip breathing, diaphragmatic breathing, individualized goals on nutrition, daily step-counts, predicted step-up and step-down heart rate on exercise, motivational and emotional attention, notification of inhaler dose/frequency, particle matters density, life-style modification, tobacco smoking cessation and dailyoffered pulmonary medical information on website/health blog. PR is offered 30 min per day, 3 days per week, targeting on 70% maximum heart rate (70MHR) in interventional arm. The control is only referral to web-based information offered at social society. Cases numbers: Intervention group is 300, the control is 150 cases (each group has equal ratio in different GOLD B/C/D categories).
